Generic drug producer Teva Pharmaceuticals (TEVA) will sell genetic testing services venture Oncotest to an Israeli company called Rhenium, reports sources. It is believed that the payment will be in the “tens of millions of dollars.” Teva is one of the largest...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
